Dianthus Therapeutics (DNTH) Misses Q1 EPS by 54c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.54). Revenue for the quarter came in at $870 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target